XML 48 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2021
Fair Value of Financial Instruments [Abstract]  
Liabilities Measured at Fair Value
The following tables summarize the liabilities that are measured at fair value as of December 31, 2021 and 2020:

   
As of December 31, 2021
 
Description
 
Level 1
   
Level 2
   
Level 3
 
Liabilities:
                 
Contingent consideration
   
-
     
-
   
$
19,930,000
 
Total
 
$
-
   
$
-
   
$
19,930,000
 

   
As of December 31, 2020
 
Description
 
Level 1
   
Level 2
   
Level 3
 
Liabilities:
                 
Contingent consideration
   
-
     
-
   
$
20,110,000
 
Total
 
$
-
   
$
-
   
$
20,110,000
 
Carrying Amount of Contingent Consideration Liabilities
Contingent consideration for the IRX Acquisition was initially valued at the transaction price and is subsequently valued at the end of each reporting period using third-party valuation services or other market observable data. The third-party valuation services use industry standard valuation models, including discounted cash flow analysis, to determine the value. After completing its validation procedures as of December 31, 2021, the Company adjusted the carrying amount of its contingent consideration liabilities as follows:

   
Year ended
December 31, 2021
 
Balance as of beginning of period
 
$
20,110,000
 
Fair value adjustments included in operating expenses
   
(180,000
)
Balance as of end of period
 
$
19,930,000